Paul Tudor Jones Cyclerion Therapeutics, Inc. Transaction History

Tudor Investment Corp Et Al

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	SELL	$2.46 - $5.84 $44,403 - $105,412	-18,050 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$1.8 - $13.43 $20,786 - $155,089	-11,548 Reduced 39.02%	18,050 $49,000
Q3 2019 Nov 14, 2019	BUY	$8.12 - $14.54 $4,482 - $8,026	552 Added 1.9%	29,598 $359,000
Q2 2019 Aug 14, 2019	BUY	$9.6 - $22.85 $278,841 - $663,701	29,046 New	29,046 $333,000

293K

Ticker CYCN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,479,800
Market Cap $130M
Description
Cyclerion Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovering, development, and commercialization of medicines for serious central nervous system (CNS) diseases. Its lead product candidate is CY6463, a CNS-penetrant, soluble guanylate cyclase (sGC) stimulator that is in Phase IIa trials for the treatment of...

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.